JAKARTA. PT Diagnos Laboratorium Utama Tbk, a healthcare support company, will carry out its initial public offering (IPO) listing on Indonesia Stock Exchange (IDX) in mid-January.
At the end of 2020, the company registered as many as 250 million units of shares in collective custody of Indonesian Central Securities Depository. Each entrusted share unit has a nominal value of IDR 25, and an offering price of IDR 200 per unit.
According to information received by idnfinancials.com, currently 51% or 510 million shares of Diagnos Laboratorium Utama is controlled by PT Bunda Investama Indonesia. Meanwhile, the remaining 49% or 490 million shares owned by PT Bundamedik. Thus, the number of new shares offered to the public is equivalent to 20% of the issued and fully paid capital.
IDX has provided DGNS recording code for Diagnos Laboratorium Utama. The shares public offering period starts from 4th to 8th January, 2021. Meanwhile, the listing of shares will be carried out on 15th January 2021.
In this IPO, they appointed PT Mirae Asset Sekuritas Indonesia as the underwriter. For information, the total assets of Diagnos Laboratorium Utama were recorded at IDR 74.67 billion at the end of first semester of 2020. (KR/VA)